Clear Eyes Recall Adds Clarity To Extent Of Impact From Altaire Sterility Concerns
Executive Summary
Number of containers recalled varies from nearly 6.7m bottles of Clear Eyes Redness Relief to 1,752 bottles of brand's Maximum Itchy Eye Relief. Updates to FDA database also include recalls of private label/store brand OTCs as agency finds more problems at manufacturers providing drugs for drug store chains, other retailers and distributors.
You may also be interested in...
Bacteria Linked To Unipharma Recall In August Identified By FDA In April
FDA says in warning letter that Unipharma was in violation of labeling rules for OTC nasal sprays as well as being non-compliant with drug GMP requirements for documenting adherence to specifications.
More Ranitidine Products, Altaire Eye Drops Among Recent OTC Recalls
Recent updates to FDA recalls database also include single lots of three package sizes of Johnson’s Baby Powder after testing found sub-trace levels of chrysotile asbestos contamination and 5,720 bottles of homeopathic OTCs made in India for West Virginia firm Washington Homeopathic Products Inc. at a facility noncompliant with the agency’s good manufacturing practices regulations.
US FDA Regulatory Roundup: Ceba-Tek GMP Warning, Altaire Expands Recall
GMP violations FDA warned Ceba-Tek about following an inspection in January and February include problems agency officials also noted in 2014 and 2015; Altaire Pharmaceuticals recalls of ophthalmic products due to lack of sterility assurance passes 500 lots, including 28 of Clear Eyes announced July 16.